Advertisement
Advertisement
ORMP
Oramed Pharmaceuticals Inc.
4.09
USDSponsored
+0.18
+4.60%
May 08, 16:00 UTC -4
Closed
After-Market
4.04
-0.04
-1.10%
ORMP Earnings Reports
Positive Surprise Ratio
ORMP beat 12 of 16 last estimates.
75%
Next Report
Date of Next Report
Aug 12, 2026
Estimate for Q2 26 (Revenue/ EPS)
--
/--
Implied change from Q4 25 (Revenue/ EPS)
--
/--
Implied change from Q2 25 (Revenue/ EPS)
--
/--
Oramed Pharmaceuticals Inc. earnings per share and revenue
On Mar 26, 2026, ORMP reported earnings of 0.24 USD per share (EPS) for Q4 25, Inline the estimate of 0.00 USD, resulting in a 0.00% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -5.14% price change (close before vs. close after earnings).
Looking ahead to Q2 26, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
BioLife Solutions Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
$0.02
Actual
$0.04
Surprise
+96.08%
Maravai LifeSciences Holdings, Inc. Class A Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.04
Actual
$0.01
Surprise
+120.79%
Varex Imaging Corporation Common Stock
Report Date
May 07, 2026 For Q2 26
Estimate
$0.21
Actual
$0.21
Surprise
-1.82%
InfuSystem Holdings, Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
$0.03
Actual
$0.05
Surprise
+46.63%
Apyx Medical Corporation Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.10
Actual
-$0.05
Surprise
+53.75%
Lantheus Holdings, Inc
Report Date
May 07, 2026 For Q1 26
Estimate
$1.26
Actual
$1.46
Surprise
+15.85%
ICU Medical Inc
Report Date
May 07, 2026 For Q1 26
Estimate
$1.78
Actual
$1.97
Surprise
+10.26%
Haemonetics Corporation
Report Date
May 07, 2026 For Q4 26
Estimate
$1.28
Actual
$1.29
Surprise
+0.42%
Rockwell Medical, Inc. (DE) Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.02
Actual
-$0.04
Surprise
-56.86%
Nephros Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
$0.01
Actual
$0.01
Surprise
-1.96%
FAQ
What were Oramed Pharmaceuticals Inc.'s earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Oramed Pharmaceuticals Inc. reported EPS of $0.24, missing estimates by 0%, and revenue of $0.00, 0% as expectations.
How did the market react to Oramed Pharmaceuticals Inc.'s Q4 2025 earnings?
The stock price moved down -5.14%, changed from $3.50 before the earnings release to $3.32 the day after.
When is Oramed Pharmaceuticals Inc. expected to report next?
The next earning report is scheduled for Aug 12, 2026.
What are the forecasts for Oramed Pharmaceuticals Inc.'s next earnings report?
Based on --
analysts, Oramed Pharmaceuticals Inc. is expected to report EPS of -- and revenue of -- for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement